On Wednesday, a Minneapolis jury ordered the Johnson & Johnson (JNJ) subsidiary Ortho-McNeil-Janssen Pharmaceuticals to pay 87-year-old John Schedin $1.7 million because its antibiotic Levaquin so damaged his Achilles tendons that he lost his ability to play golf and walk through malls. Company spokesman Michael Heinley told DailyFinance, “We're disappointed with the jury's decision and will vigorously defend against plaintiff's claims on appeal.”

The verdict is the first from approximately 2,600 similar lawsuits that have been filed so far in state and federal courts nationwide. More than 430 million prescriptions have been written for Levaquin, so more suits could follow.

Read the full DailyFinance story, “Johnson & Johnson Subsidiary Loses First Levaquin Lawsuit.”